11/21
11:02 am
crl
Bioburden Testing Market Analysis Report 2024-2030: Outsourcing Surge Boosts Bioburden Testing Services as CMOs Expand Globally [Yahoo! Finance]
Low
Report
Bioburden Testing Market Analysis Report 2024-2030: Outsourcing Surge Boosts Bioburden Testing Services as CMOs Expand Globally [Yahoo! Finance]
11/18
10:29 am
crl
EW Healthcare Partners Announces Leadership Evolution [Yahoo! Finance]
Low
Report
EW Healthcare Partners Announces Leadership Evolution [Yahoo! Finance]
11/18
08:50 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at CLSA from a "hold" rating to an "underperform" rating. They now have a $164.00 price target on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at CLSA from a "hold" rating to an "underperform" rating. They now have a $164.00 price target on the stock.
11/14
09:34 am
crl
Sterility Testing Market Valuation Set to Worth Over US$ 2,945.74 Million By 2032 | Membrane Filtration Test to Remain the Most Prominent and Highly Preferred Says Astute Analytica [Yahoo! Finance]
Medium
Report
Sterility Testing Market Valuation Set to Worth Over US$ 2,945.74 Million By 2032 | Membrane Filtration Test to Remain the Most Prominent and Highly Preferred Says Astute Analytica [Yahoo! Finance]
11/13
01:14 pm
crl
Insight into Murray Stahl's Strategic Moves: A Focus on Bitcoin Trust and Digital Assets [Yahoo! Finance]
Low
Report
Insight into Murray Stahl's Strategic Moves: A Focus on Bitcoin Trust and Digital Assets [Yahoo! Finance]
11/13
12:31 pm
crl
'Serious risks': Researchers join push against importing monkeys for drug testing [Yahoo! Finance Canada]
Low
Report
'Serious risks': Researchers join push against importing monkeys for drug testing [Yahoo! Finance Canada]
11/12
07:30 am
crl
Bioanalytical Testing Services Market to Surpass USD 9.22 Billion by 2032, Predicted CAGR of 9.4%| Polaris Market Research [Yahoo! Finance]
Low
Report
Bioanalytical Testing Services Market to Surpass USD 9.22 Billion by 2032, Predicted CAGR of 9.4%| Polaris Market Research [Yahoo! Finance]
11/11
11:18 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at TD Cowen from $203.00 to $227.00. They now have a "hold" rating on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at TD Cowen from $203.00 to $227.00. They now have a "hold" rating on the stock.
11/11
08:00 am
crl
Charles River Laboratories to Present at UBS and Jefferies Conferences
Low
Report
Charles River Laboratories to Present at UBS and Jefferies Conferences
11/8
06:36 am
crl
Charles River Laboratories International Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Low
Report
Charles River Laboratories International Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
11/7
11:20 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at UBS Group AG from $240.00 to $250.00. They now have a "buy" rating on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at UBS Group AG from $240.00 to $250.00. They now have a "buy" rating on the stock.
11/7
09:50 am
crl
$56.72 Bn Drug Discovery Services Market Opportunities and Strategies to 2033: Comprehensive Solutions for Enhanced Biotech Industry Support, Strategic Collaborations Among Major Players [Yahoo! Finance]
Low
Report
$56.72 Bn Drug Discovery Services Market Opportunities and Strategies to 2033: Comprehensive Solutions for Enhanced Biotech Industry Support, Strategic Collaborations Among Major Players [Yahoo! Finance]
11/7
09:03 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) was upgraded by analysts at CLSA from an "underperform" rating to a "hold" rating. They now have a $205.00 price target on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) was upgraded by analysts at CLSA from an "underperform" rating to a "hold" rating. They now have a $205.00 price target on the stock.
11/7
09:00 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at Evercore ISI from $190.00 to $225.00. They now have an "in-line" rating on the stock.
Medium
Report
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at Evercore ISI from $190.00 to $225.00. They now have an "in-line" rating on the stock.
11/7
02:31 am
crl
Charles River Laboratories International Inc (CRL) Q3 2024 Earnings Call Highlights: Navigating ... [Yahoo! Finance]
Low
Report
Charles River Laboratories International Inc (CRL) Q3 2024 Earnings Call Highlights: Navigating ... [Yahoo! Finance]
11/7
12:09 am
crl
Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight [Yahoo! Finance]
Low
Report
Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight [Yahoo! Finance]
11/6
11:24 am
crl
Charles River (CRL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
Low
Report
Charles River (CRL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
11/6
07:00 am
crl
Charles River Laboratories Announces Third-Quarter 2024 Results
High
Report
Charles River Laboratories Announces Third-Quarter 2024 Results
11/4
10:47 am
crl
Gear Up for Charles River (CRL) Q3 Earnings: Wall Street Estimates for Key Metrics [Yahoo! Finance]
Low
Report
Gear Up for Charles River (CRL) Q3 Earnings: Wall Street Estimates for Key Metrics [Yahoo! Finance]
11/2
07:46 pm
crl
Regional Growth Partnership highlights Lima area's success [Yahoo! Finance]
Low
Report
Regional Growth Partnership highlights Lima area's success [Yahoo! Finance]
10/30
12:21 pm
crl
Ottawa urged to halt imports of endangered monkeys for drug testing, amid U.S. probe [Yahoo! Finance Canada]
Low
Report
Ottawa urged to halt imports of endangered monkeys for drug testing, amid U.S. probe [Yahoo! Finance Canada]
10/29
06:33 pm
crl
Fragment Based Drug Discovery Market Size Projected to Achieve USD 2.1 Billion by 2031, Expanding at a 11.5% CAGR | Analysis by Transparency Market Research, Inc. [Yahoo! Finance]
Low
Report
Fragment Based Drug Discovery Market Size Projected to Achieve USD 2.1 Billion by 2031, Expanding at a 11.5% CAGR | Analysis by Transparency Market Research, Inc. [Yahoo! Finance]
10/23
07:35 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) is now covered by analysts at CLSA. They set an "underperform" rating and a $167.00 price target on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) is now covered by analysts at CLSA. They set an "underperform" rating and a $167.00 price target on the stock.
10/17
08:00 am
crl
Charles River Launches New Retrogenix® Non-Human Protein Library
Low
Report
Charles River Launches New Retrogenix® Non-Human Protein Library
10/16
04:30 pm
crl
Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call
Low
Report
Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call